Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804037617> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2804037617 endingPage "1735" @default.
- W2804037617 startingPage "1729" @default.
- W2804037617 abstract "Caffeic acid phenethyl ester and Dasatinib in combination, when used incongruous proportions and durations, present an antitumor potential for glioma in vitro, suggesting a high therapeutic potential for glioma treatment.In the present study, we addressed the question whether CAPE and Dasatinib target multiple pathways involved in tumor growth, proliferation and development on an in vivo rat model of glioma.Expression analysis of proteins thought to be mediating proliferation, cell motility, angiogenesis, and invasion was carried out to delineate the antineoplastic action of CAPE and Dasatinib.CAPE and Dasatinib modulate the expression of proteins having potential interactive crosstalk with major oncogenic pathways involved in glioma progression. Our results showed that combination treatment modulates the expression of p53 in group co-administered with CAPE and Dasatinib after glioma induction in comparison to the group induced with glioma only. EGFR and PCNA expression were significantly altered in the co-treated group in comparison with the glioma-induced group. The effects of CAPE and Dasatinib treatment were further evaluated on the AKT pathway by Western blot analysis. The co-treated group showed a significant reduction in the expression of AKT. The histopathological analysis further backed the antiproliferative and anti invasive effects of CAPE and Dasatinib.This study in totality suggests that the combinational therapy remarkably reduces the proliferation of glioma cells in vivo, suggesting that CAPE and Dasatinib therapy could be exploited for the management of gliomas without showing drug-related resistances and side effects, suggesting a high therapeutic potential of the therapy in glioma." @default.
- W2804037617 created "2018-06-01" @default.
- W2804037617 creator A5031525750 @default.
- W2804037617 creator A5032384338 @default.
- W2804037617 creator A5069464766 @default.
- W2804037617 creator A5081000126 @default.
- W2804037617 date "2019-01-29" @default.
- W2804037617 modified "2023-10-16" @default.
- W2804037617 title "Anti-glioma Effects of Caffeic Acid Phenethyl Ester and Dasatinib Combination Therapy in an in vivo Rat Glioma Model" @default.
- W2804037617 doi "https://doi.org/10.2174/1871520618666180515144835" @default.
- W2804037617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29766825" @default.
- W2804037617 hasPublicationYear "2019" @default.
- W2804037617 type Work @default.
- W2804037617 sameAs 2804037617 @default.
- W2804037617 citedByCount "2" @default.
- W2804037617 countsByYear W28040376172020 @default.
- W2804037617 countsByYear W28040376172023 @default.
- W2804037617 crossrefType "journal-article" @default.
- W2804037617 hasAuthorship W2804037617A5031525750 @default.
- W2804037617 hasAuthorship W2804037617A5032384338 @default.
- W2804037617 hasAuthorship W2804037617A5069464766 @default.
- W2804037617 hasAuthorship W2804037617A5081000126 @default.
- W2804037617 hasConcept C150903083 @default.
- W2804037617 hasConcept C185592680 @default.
- W2804037617 hasConcept C207001950 @default.
- W2804037617 hasConcept C2776992468 @default.
- W2804037617 hasConcept C2776999253 @default.
- W2804037617 hasConcept C2777583451 @default.
- W2804037617 hasConcept C2778004101 @default.
- W2804037617 hasConcept C2778224086 @default.
- W2804037617 hasConcept C2778227246 @default.
- W2804037617 hasConcept C2778729363 @default.
- W2804037617 hasConcept C2779536868 @default.
- W2804037617 hasConcept C502942594 @default.
- W2804037617 hasConcept C55493867 @default.
- W2804037617 hasConcept C62478195 @default.
- W2804037617 hasConcept C71924100 @default.
- W2804037617 hasConcept C75217442 @default.
- W2804037617 hasConcept C86803240 @default.
- W2804037617 hasConcept C98274493 @default.
- W2804037617 hasConceptScore W2804037617C150903083 @default.
- W2804037617 hasConceptScore W2804037617C185592680 @default.
- W2804037617 hasConceptScore W2804037617C207001950 @default.
- W2804037617 hasConceptScore W2804037617C2776992468 @default.
- W2804037617 hasConceptScore W2804037617C2776999253 @default.
- W2804037617 hasConceptScore W2804037617C2777583451 @default.
- W2804037617 hasConceptScore W2804037617C2778004101 @default.
- W2804037617 hasConceptScore W2804037617C2778224086 @default.
- W2804037617 hasConceptScore W2804037617C2778227246 @default.
- W2804037617 hasConceptScore W2804037617C2778729363 @default.
- W2804037617 hasConceptScore W2804037617C2779536868 @default.
- W2804037617 hasConceptScore W2804037617C502942594 @default.
- W2804037617 hasConceptScore W2804037617C55493867 @default.
- W2804037617 hasConceptScore W2804037617C62478195 @default.
- W2804037617 hasConceptScore W2804037617C71924100 @default.
- W2804037617 hasConceptScore W2804037617C75217442 @default.
- W2804037617 hasConceptScore W2804037617C86803240 @default.
- W2804037617 hasConceptScore W2804037617C98274493 @default.
- W2804037617 hasIssue "12" @default.
- W2804037617 hasLocation W28040376171 @default.
- W2804037617 hasLocation W28040376172 @default.
- W2804037617 hasOpenAccess W2804037617 @default.
- W2804037617 hasPrimaryLocation W28040376171 @default.
- W2804037617 hasRelatedWork W2112223455 @default.
- W2804037617 hasRelatedWork W2285709798 @default.
- W2804037617 hasRelatedWork W2804037617 @default.
- W2804037617 hasRelatedWork W2808959447 @default.
- W2804037617 hasRelatedWork W2893314773 @default.
- W2804037617 hasRelatedWork W2947842923 @default.
- W2804037617 hasRelatedWork W2980807285 @default.
- W2804037617 hasRelatedWork W3022564264 @default.
- W2804037617 hasRelatedWork W3164029683 @default.
- W2804037617 hasRelatedWork W3216750786 @default.
- W2804037617 hasVolume "18" @default.
- W2804037617 isParatext "false" @default.
- W2804037617 isRetracted "false" @default.
- W2804037617 magId "2804037617" @default.
- W2804037617 workType "article" @default.